These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1302295)

  • 1. [Myelodysplasia, hemolysis, and infections].
    Medicina (B Aires); 1992; 52(1):65-71. PubMed ID: 1302295
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
    Chen YC; Chou JM; Letendre L; Li CY
    Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoid pneumonia with chronic myelomonocytic leukemia.
    Itoh Y; Segawa H; Kito K; Hodohara K; Ishigaki H; Sugihara H; Fujiyama Y; Ogasawara K
    Pathol Res Pract; 2009; 205(2):143-7. PubMed ID: 18805647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 6. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
    Kaiserling E; Horny HP; Geerts ML; Schmid U
    Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence re: Kaiserling E, Horny HP, Geerts M-L, Schmid U: Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol 7:771, 1994.
    Orazi A
    Mod Pathol; 1995 Apr; 8(3):340-1. PubMed ID: 7542388
    [No Abstract]   [Full Text] [Related]  

  • 9. Testicular extramedullary myeloid cell tumor in a patient with myelodysplastic syndrome.
    Saxena A; Saidman B; Greenwald D; Wasik MA
    Arch Pathol Lab Med; 1996 Apr; 120(4):389-92. PubMed ID: 8619753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
    Randi ML; Fabris F; Girolami A
    Haematologica; 1999 Nov; 84(11):1049-50. PubMed ID: 10553169
    [No Abstract]   [Full Text] [Related]  

  • 12. Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestions.
    Lichtman MA
    Blood Cells Mol Dis; 2021 May; 88():102546. PubMed ID: 33578137
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Castoldi G
    Haematologica; 1997; 82(1):25-30. PubMed ID: 9107078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.
    Miguel A; Orero M; Simon R; Collado R; Perez PL; Pacios A; Iglesias R; Martinez A; Carbonell F
    Lab Hematol; 2007; 13(3):98-102. PubMed ID: 17984041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes.
    Kalmantis T; Kalmanti M; Vassilaki M; Spandidos DA
    Anticancer Res; 1993; 13(4):1103-6. PubMed ID: 8352532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Weeks LD; Marinac CR; Redd R; Abel G; Lin A; Agrawal M; Stone RM; Schrag D; Ebert BL
    Blood; 2022 Feb; 139(8):1246-1250. PubMed ID: 34875037
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic myelomonocytic leukemia--myelodysplastic syndrome].
    Wickramanayake PD; Pallenschat J; Diehl V
    Med Klin (Munich); 1991 Aug; 86(8):383-6. PubMed ID: 1921902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic myelomonocytic leukemia].
    Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
    Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.
    Ueki K; Sato S; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J
    J Med; 1991; 22(3):157-61. PubMed ID: 1770323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.